Trualt Bioenergy Intrinsic Value
Trualt Bioenergy (TRUALT) median intrinsic value is ₹163.84 from 4 valuation models (range ₹108–₹629), vs current price ₹409.60 — -60.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit Trualt Bioenergy stock price NSE .
TRUALT Valuation Methods Summary — DCF, Graham Number & P/E
Trualt Bioenergy intrinsic value across 4 models vs current price ₹409.60 — upside/downside and value range per method. Browse TRUALT cash flow statement for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹108.31 | ₹97.48 - ₹119.14 | -73.6% | Book Value/Share: ₹108.31, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹122.88 | ₹110.59 - ₹135.17 | -70.0% | Revenue/Share: ₹73.24, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹163.84 | ₹147.46 - ₹180.22 | -60.0% | EBITDA: ₹40.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹629.42 | ₹503.54 - ₹755.30 | +53.7% | CF Growth: 15.0%, Discount: 15% |
TRUALT Intrinsic Value vs Market Price — All Valuation Models
Trualt Bioenergy fair value range ₹108–₹629 vs current market price ₹409.60 across 4 valuation models. Compare with Trualt Bioenergy valuation methods to assess whether the stock is under or overvalued.
TRUALT Intrinsic Value Analysis — Undervalued or Overvalued?
Trualt Bioenergy median intrinsic value ₹163.84, current price ₹409.60 — Trading Above Calculated Value by 60.0%, margin of safety -100.0%.
What is the intrinsic value of TRUALT?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Trualt Bioenergy (TRUALT) is ₹163.84 (median value). With the current market price of ₹409.60, this represents a -60.0% variance from our estimated fair value.
The valuation range spans from ₹108.31 to ₹629.42, indicating ₹108.31 - ₹629.42.
Is TRUALT undervalued or overvalued?
Based on our multi-method analysis, Trualt Bioenergy (TRUALT) appears to be trading above calculated value by approximately 60.0%.
TRUALT Financial Health — Key Ratios vs Industry Benchmarks
Trualt Bioenergy financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.88 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | -19.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.17x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
TRUALT Cash Flow Quality — Operating & Free Cash Flow
Trualt Bioenergy operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹329 Cr | ₹208 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹36 Cr | ₹-156 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹234 Cr | ₹-341 Cr | Positive Operating Cash Flow | 6/10 |